4 ms·
In the article the drug maker suggestss that rather than negotiate the price down, US insurers stop buying the drug if he cuts the price too low. That seems li
by ZeroGravitas 2y ago
In the article the drug maker suggestss that rather than negotiate the price down, US insurers stop buying the drug if he cuts the price too low.
That seems like a wild claim to make, but since it's just reported as if that was normal rather than a shocking scandal, I guess it's probably true.
- whaleofatw2022 2y agoIt's part of the grift. Expensive drugs means all sorts of middle men negotiate concessions to make themselves get better performance reviews.